KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Brunswick (BC) Research & Development (2016 - 2025)

Brunswick (BC) has disclosed Research & Development for 16 consecutive years, with $45.0 million as the latest value for Q4 2025.

  • On a quarterly basis, Research & Development rose 15.09% to $45.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $168.7 million, a 0.53% decrease, with the full-year FY2025 number at $168.7 million, down 0.53% from a year prior.
  • Research & Development was $45.0 million for Q4 2025 at Brunswick, up from $43.4 million in the prior quarter.
  • In the past five years, Research & Development ranged from a high of $51.4 million in Q2 2022 to a low of $34.1 million in Q2 2021.
  • A 5-year average of $44.0 million and a median of $44.2 million in 2025 define the central range for Research & Development.
  • Peak YoY movement for Research & Development: soared 50.73% in 2022, then dropped 16.7% in 2023.
  • Brunswick's Research & Development stood at $47.4 million in 2021, then grew by 7.38% to $50.9 million in 2022, then fell by 16.7% to $42.4 million in 2023, then dropped by 7.78% to $39.1 million in 2024, then increased by 15.09% to $45.0 million in 2025.
  • Per Business Quant, the three most recent readings for BC's Research & Development are $45.0 million (Q4 2025), $43.4 million (Q3 2025), and $41.8 million (Q2 2025).